DEBIOPHARM GROUP
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.
DEBIOPHARM GROUP
Industry:
Biotechnology Medical Medical Device Pharmaceutical
Founded:
1979-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.debiopharm.com
Total Employee:
251+
Status:
Active
Contact:
+41213210111
Total Funding:
4.7 M USD
Technology used in webpage:
Apple Mobile Web Clips Icon Amazon ASP.NET IIS Amazon Virginia Region Java EE Lorem Ipsum WordPress 5.8 Apple Whitelist IIS 7
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Nanoform Therapeutics
Nanoform Therapeutics develops new generation of Bio-Pharmaceutical developmental or marketed drugs.
Current Employees Featured
Thierry Mauvernay
Thierry Mauvernay President & Delegate of the Board @ Debiopharm Group President & Delegate of the Board
Sophie Genecand
Sophie Genecand Director, Real Estate department, Debiopharm Investment S.A. @ Debiopharm Group Director, Real Estate department, Debiopharm Investment S.A.
ANGELA ZUBEL
ANGELA ZUBEL Chief Development Officer @ Debiopharm Group Chief Development Officer 2019-02-01
Bertrand Ducrey
Bertrand Ducrey CEO @ Debiopharm Group CEO 2012-01-01
Raymond Zaugg
Raymond Zaugg Director, Financial department, Debiopharm Investment S.A @ Debiopharm Group Director, Financial department, Debiopharm Investment S.A
Riccardo Nisato
Riccardo Nisato Licensing and Grants Associate Manager @ Debiopharm Group Licensing and Grants Associate Manager 2021-04-01
Alexandra Le Coz Sanchez
Alexandra Le Coz Sanchez Associate Director, Private Equity Department, Debiopharm Investment S.A. @ Debiopharm Group Associate Director, Private Equity Department, Debiopharm Investment S.A.
Founder
Rolland-Yves Mauvernay
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2014-02-11 | Affinium Pharmaceuticals | Affinium Pharmaceuticals acquired by Debiopharm Group | N/A |
Investors List
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2020-01-09 | Novadiscovery | Debiopharm Group investment in Series A - Novadiscovery | 5 M EUR |
2019-11-10 | Little Green House | Debiopharm Group investment in Corporate Round - Little Green House | N/A |
2016-10-26 | Coorpacademy | Debiopharm Group investment in Series B - Coorpacademy | 10 M EUR |
2015-04-03 | Immunexpress | Debiopharm Group investment in Debt Financing - Immunexpress | 40 M USD |
2014-11-17 | Coorpacademy | Debiopharm Group investment in Series A - Coorpacademy | 3.2 M EUR |
2014-05-05 | Immunexpress | Debiopharm Group investment in Series B - Immunexpress | 18 M USD |
2014-03-05 | Immunexpress | Debiopharm Group investment in Funding Round - Immunexpress | 6 M USD |
2013-12-03 | BPA Solutions | Debiopharm Group investment in Funding Round - BPA Solutions | N/A |
2013-09-06 | Skioo | Debiopharm Group investment in Venture Round - Skioo | N/A |
2013-05-22 | Urturn | Debiopharm Group investment in Series A - Urturn | 13.4 M USD |
Newest Events participated
Participated in Swiss Startup Day
on 2015-10-21 as sponsor
Official Site Inspections
http://www.debiopharm.com Semrush global rank: 4.77 M Semrush visits lastest month: 1.93 K
- Host name: havps24.iron.bsa.oriented.ch
- IP address: 185.15.230.34
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
Loading ...